Suppr超能文献

醛糖还原酶抑制剂——预防糖尿病性晶状体改变的新途径?

[Aldose reductase inhibitor--a new way for preventing diabetic lens changes?].

作者信息

Ohrloff C, Hockwin O, Korte I, Wegener A

出版信息

Klin Monbl Augenheilkd. 1986 Nov;189(5):361-2. doi: 10.1055/s-2008-1050822.

Abstract

Increased blood sugar levels may influence the refractive power of the lens in juvenile diabetics, and can lead to the rare true diabetic cataract ("snow-storm cataract"). Surplus glucose induces accumulation of the sugar alcohol within the cells, thus generating disturbances of the osmotic balance and finally causing cataract. The enzyme aldose reductase catalyzes the formation of sorbitol. Experiments with animals have shown that aldose reductase inhibitors can prevent the formation of such opacities with streptozotocin-induced diabetes in rats. Numerous aldose reductase inhibitors are now known, but we still have insufficient knowledge to determine whether systemic or local administration is preferable. The mechanisms reported here are not relevant with respect to the frequent occurrence of senile cataract in older diabetics, which has often been described.

摘要

血糖水平升高可能会影响青少年糖尿病患者晶状体的屈光能力,并可能导致罕见的真性糖尿病性白内障(“暴风雪样白内障”)。多余的葡萄糖会诱导细胞内糖醇的积累,从而产生渗透平衡紊乱,最终导致白内障。醛糖还原酶催化山梨醇的形成。动物实验表明,醛糖还原酶抑制剂可以预防链脲佐菌素诱导的大鼠糖尿病性白内障的形成。目前已知有许多醛糖还原酶抑制剂,但我们仍缺乏足够的知识来确定全身给药还是局部给药更可取。这里报道的机制与老年糖尿病患者中经常出现的老年性白内障无关,老年性白内障经常被描述。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验